![]() ![]() | Lajous, H., Riva, R., Lelièvre, B., Tétaud, C., Avril, S., Hindré, F., Boury, F., Jérôme, C., Lecomte, P., & Garcion, E. (01 September 2018). Hybrid Gd3+/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines. Biomaterials Science, 6 (9), 2386-2409. doi:10.1039/C8BM00346G ![]() |
Lajous, H. (2018). Cisplatine : une vieille molécule pour de nouveaux défis. Développement d'une prodrogue polymère macromoléculaire multifonctionnelle applicable au traitement local du glioblastome [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/224478 |
Lajous, H., Riva, R., Lecomte, P., & Garcion, E. (31 May 2016). Development and preclinical evaluation of multifunctional nanodevices for the treatment of glioblastoma: first biological assays [Poster presentation]. Journée scientifique de la SFR-ICAT4208, Angers, France. |
Lajous, H., Riva, R., Lecomte, P., & Garcion, E. (December 2015). Development and preclinical evaluation of multifunctional nanodevices for the treatment of glioblastom [Poster presentation]. European Nanomecine Meeting 2015, Grenoble, France. |
Lajous, H., Riva, R., Lecomte, P., & Garcion, E. (October 2015). Development and preclinical evaluation of multifunctional nanodevices for the treatment of glioblastoma: polymer synthesis and first formulation assays [Poster presentation]. NanoFar autumn school, Nantes, France. |
Lajous, H., Riva, R., Lecomte, P., & Garcion, E. (02 July 2015). Development and preclinical evaluation of multifunctional nanodevices for the treatment of glioblastoma: synthesis aspects [Poster presentation]. Journée du département de Chimie, Liege, Belgium. |